Phase 1 to Evaluate the Safety and Pharmacokinetic Durg-drug Interaction of YYC506-T and YYC506-A
Clinical trial NCT04874142 · COMPLETED
Trial details
- NCT number
- NCT04874142
- Sponsor
- Yooyoung Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-20
- Primary completion
- 2020-03-23
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.